TRCT
GDNR

Tower Research Capital (TRC)’s Gardiner Healthcare Acquisitions Corp. Common Stock GDNR Stock Holding History

Tower Research Capital (TRC)’s Portfolio GDNR Stock Details GDNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,540
Closed -$27.6K – 6292
2023
Q3 		$27.6K Hold
2,540
– – ﹤0.01% 3094
2023
Q2 		$27.2K Buy
2,540
+57
+2% +$606 ﹤0.01% 3116
2023
Q1 		$26K Sell
2,483
-100
-4% -$1.04K ﹤0.01% 3186
2022
Q4 		$27K Sell
2,583
-36
-1% -$364 ﹤0.01% 2861
2022
Q3 		$26K Buy
2,619
+101
+4% +$1.01K ﹤0.01% 3736
2022
Q2 		$25K Buy
2,518
+538
+27% +$5.34K ﹤0.01% 3583
2022
Q1 		$20K Buy
+1,980
New +$19.5K ﹤0.01% 3558

Tower Research Capital (TRC)'s GDNR Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Gardiner Healthcare Acquisitions Corp. Common Stock (GDNR) in Q4 2023, closing a stake of 2,540 shares — an estimated $27.6K sold.

Tower Research Capital (TRC) first reported a position in GDNR in Q1 2022 and held it in 7 quarters. The position peaked at $27.6K in Q3 2023. 0 funds tracked by Wall St. Rank hold GDNR as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Gardiner Healthcare Acquisitions Corp. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,540 Gardiner Healthcare Acquisitions Corp. Common Stock shares in Q4 2023, an estimated $27.6K.
  • Tower Research Capital (TRC) first reported a position in Gardiner Healthcare Acquisitions Corp. Common Stock in Q1 2022 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Gardiner Healthcare Acquisitions Corp. Common Stock position peaked at $27.6K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Gardiner Healthcare Acquisitions Corp. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.